Decreased STARD10 expression is associated with defective insulin secretion in humans and mice.
Genetic variants near ARAP1 (CENTD2) and STARD10 influence type 2 diabetes (T2D) risk. The risk alleles impair glucose-induced insulin secretion and, paradoxically but characteristically, are associated with decreased proinsulin:insulin ratios, indicating improved proinsulin conversion. Neither the...
Κύριοι συγγραφείς: | Carrat, G, Hu, M, Nguyen-Tu, M, Chabosseau, P, Gaulton, K, van de Bunt, M, Siddiq, A, Falchi, M, Thurner, M, Canouil, M, Pattou, F, Leclerc, I, Pullen, T, Cane, M, Prabhala, P, Greenwald, W, Schulte, A, Marchetti, P, Ibberson, M, MacDonald, P, Manning Fox, J, Gloyn, A, Froguel, P, Solimena, M, McCarthy, M, Rutter, G |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Elsevier
2017
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Decreased STARD10 expression is associated with defective insulin secretion in humans and mice
ανά: Carrat, G, κ.ά.
Έκδοση: (2017) -
The type 2 diabetes gene product STARD10 is a phosphoinositide binding protein that controls insulin secretory granule biogenesis
ανά: Carrat, GR, κ.ά.
Έκδοση: (2020) -
Changes in the expression of the type 2 diabetes-associated gene VPS13C in the β cell are associated with glucose intolerance in humans and mice
ανά: Mehta, Z, κ.ά.
Έκδοση: (2016) -
Changes in the expression of the type 2 diabetes-associated gene VPS13C in the β-cell are associated with glucose intolerance in humans and mice.
ανά: Mehta, Z, κ.ά.
Έκδοση: (2016) -
[Diagnostic (STARD) and prognostic (REMARK) studies].
ανά: Altman, D, κ.ά.
Έκδοση: (2005)